Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2025 Earnings and Company Updates
CAMBRIDGE, Mass., May 01, 2025 ( GLOBE NEWSWIRE ) -- Intellia Therapeutics, Inc. ( NASDAQ:NTLA ) , a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, will present its first quarter 2025 financial results and operational highlights in a ...
https://www.globenewswire.com/news-release/2025/05/01/3072258/0/en/Intellia-Therapeutics-to-Hold-Conference-Call-to-Discuss-First-Quarter-2025-Earnings-and-Company-Updates.html